BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Neuland Laboratories Ltd Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
524558
ISIN Demat
INE794A01010
Book Value (Rs)
1255.9414887
NSE Symbol
NEULANDLAB
Divident Yield %
0.1
Market Cap
(Rs In Cr.)
16,235
P/E (TTM)
91.05
EPS (TTM)
138.98
Face Value
(Rs)
10
Back
Neuland Laboratories consolidated net profit rises 194.91% in the September 2025 quarter
08-Nov-25   Hrs IST

Net profit of Neuland Laboratories rose 194.91% to Rs 96.85 crore in the quarter ended September 2025 as against Rs 32.84 crore during the previous quarter ended September 2024. Sales rose 65.45% to Rs 514.27 crore in the quarter ended September 2025 as against Rs 310.84 crore during the previous quarter ended September 2024.

ParticularsQuarter Ended
Sep. 2025Sep. 2024% Var.
Sales514.27310.84 65
OPM %30.2520.02 -
PBDT151.9865.50 132
PBT129.4449.42 162
NP96.8532.84 195

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed and Maintained by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)